Search for Clinical Trial Results

Sponsored By

Progressive Familial Intrahepatic Cholestasis 1 - 9 Studies Found

Status Study
No longer available Study Name: Buphenyl Therapy for Byler's Disease
Condition: Byler Disease
Date: 2013-02-04
Interventions: Drug: Buphenyl
No longer available Study Name: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
Condition: Byler Disease
Date: 2013-09-20
Interventions: Drug: Glycerol phenylbutyrate Other Name: RAVICTI
Temporarily not available Study Name: Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease
Condition: Byler Disease
Date: 2014-03-19
Interventions: Drug: RAVICTI open label expanded access protocol of titrated dosing regimen of RAVICTI for up to 60 wee
Active, not recruiting Study Name: Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)
Date: 2014-02-05
Interventions: Drug: LUM001 LUM001 oral dose
Completed Study Name: Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease
Condition:
  • Alagille Syndrome
  • Progressive Familial Intrahepatic Cholestasis
    Date: 2014-05-01
Completed Study Name: An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects
Condition:
  • Orphan Cholestatic Liver Diseases
  • Progressive Familial Intrahepatic Ch
    Date: 2017-02-27
    Interventions: Drug: 3 mg [14C]-A4250 capsule Each subject will receive a single administration of 3 mg [14C]-A4250 cap
Completed Study Name: A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384
Condition:
  • Orphan Cholestatic Liver Diseases
  • Primary Biliary Cirrhosis
  • Drug: A4250
  • Drug: CRC (A3384)
Completed Study Name: Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
Condition: Hepatobiliary Diseases
Date: 2010-08-31
Recruiting Study Name: Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)
Condition:
  • Liver Diseases
  • Alagille Syndrome
  • Alpha 1-Antitrypsin Defic
    Date: 2007-12-07